Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200824 · ClinicalTrials.gov registry record · Phase 2
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00200824 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00200824, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the body) in prostate tissue that has been removed during prostatectomy, as well as in the blood.
Interventions
- DRUG Soy Isoflavone Nutritional Supplements
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-05 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200824
The ClinicalTrials.gov registry entry for NCT00200824 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soy Isoflavone Nutritional Supplements is the first listed.
NCT00200824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200824 about?
NCT00200824 is a clinical study titled "Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health". This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the ...
What is the current status of trial NCT00200824?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-05. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00200824?
The interventions under investigation include: Soy Isoflavone Nutritional Supplements (DRUG).
Who is sponsoring clinical trial NCT00200824?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.